Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Malia
Michael J. Malia, Owego, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090191751 | COAXIAL CABLE ALIGNMENT ENHANCER FOR USE WITHIN COAXIAL CABLE ASSEMBLIES SO AS TO ENSURE THE PROPER COAXIAL DISPOSITION OF THE COAXIAL CABLE CONTACT MEMBERS OF COAXIAL CABLE ELECTRICAL CONNECTORS - A coaxial cable assembly comprises a coaxial cable alignment enhancer which has a plurality of axially oriented recesses defined within its outer peripheral surface portion for accommodating a plurality of electrical cables. A securing member is disposed around the alignment enhancer so as to in fact maintain the plurality of cables disposed within the recesses. In this manner, the plurality of cables are in fact disposed in a true coaxial manner with respect to each other whereby electrical contact members of the cables are, in turn, disposed in a true coaxial manner with respect to each other so as to be capable of being engaged with corresponding electrical contact members of another electrical connector without experiencing any deformation and damage. | 07-30-2009 |
Tara Anne Malia, Manasquan, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110306267 | Creative illustration book - A creative illustration book is provided that has a story page that has pre-printed text of a written story. An illustration page is included that does not have any of the pre-printed text of the written story thereon. The illustration page is removable from the book so that the entire written story is retained in the book after removal of the illustration page. The illustration page is provided for use in having a user draw an illustration thereon. | 12-15-2011 |
Thomas Malia, Radnor, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110236390 | IL-17A Antagonists - Interleukin-17A (IL-17A) antibody antagonists, polynucleotides encoding IL-17A antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 09-29-2011 |
